drugset / Trial / NCT00565175

Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia

NCT00565175

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to investigate whether blockade of the histamine H2 receptors in the brain will have any beneficial effect on the symptoms of subjects with schizophrenia.

Timeline

Start
2008-01
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Famotidine Other / unclassified 100 mg Oral

Indications